EUVIMEDEUVIMED entdecken
Crossref

Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S.

Liam Bendicksen iD, Aaron S Kesselheim

Journal of Law, Medicine & Ethics · 2023

DOI: 10.1017/jme.2023.76 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Law, Medicine & Ethics, 2023. Verfasst von Liam Bendicksen und 1 weiteren Autor:innen. Beteiligte Einrichtung: PORTAL, BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA, USA. Hauptthemen laut MEDLINE: Abortion, Induced, Prescription Drugs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Legal challenges to the FDA’s approval of mifepristone have destabilized patients’ ability to access controversial medicines like medication abortion. We argue that federal courts’ receptiveness to this litigation undermines the coherence and integrity of prescription drug regulation in the U.S.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, InducedPrescription DrugsFemalePregnancyHumansDrug Approval

Stichwörter der Autor:innen

Drug ApprovalsFederal CourtsMedication AbortionMifepristoneU.S. Food and Drug Administration

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • PORTAL, BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA, USA.
  • HARVARD MEDICAL SCHOOL, BOSTON, MA, USA.

ORCID-Profile: Liam Bendicksen

Zitieren

APA

Bendicksen, L., & Kesselheim, A. S. (2023). Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S. Journal of Law, Medicine & Ethics. https://doi.org/10.1017/jme.2023.76

Vancouver

Bendicksen L, Kesselheim AS. Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S. Journal of Law, Medicine & Ethics. 2023. doi:10.1017/jme.2023.76

BibTeX
@article{Bendicksen2023,
  author = {Bendicksen, Liam and Kesselheim, Aaron S},
  title = {Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S},
  journal = {Journal of Law, Medicine & Ethics},
  year = {2023},
  doi = {10.1017/jme.2023.76}
}
Kostenlos starten →